Delivery Order SPE2DB22D1017-SPE2DB24FF4FK
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,211.59 firm fixed-price delivery order is for the supply of Myrbetriq ER 25 mg tablets with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, is for the delivery of Myrbetriq ER 50 mg tablets. The $10,585.83 firm fixed price delivery order has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,278.85 firm fixed-price delivery order is for the supply of the medication Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $21,460.01 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4,564,185,904 units of the pharmaceutical product Myrbetriq ER 25 mg tablets, with an ultimate completion date of April 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,618.18 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets, with a performance period through February 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,841.66 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is a part of a larger indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $22,287.69, is a firm fixed price delivery order for the medication Myrbetriq ER 50 mg tablets. The award has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
- This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,657.92 firm fixed-price contract is for the supply of Myrbetriq ER 25 MG tablets. The contract has an ultimate completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $6,385.87 firm fixed price contract is for the supply of the medication Myrbetriq ER 50 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,560.78 firm fixed-price delivery order is for the supply of the medication Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4FKDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $5,280.59 firm fixed price delivery order is for the supply of 4,563,956,681 units of the drug Myrbetriq ER 50 mg tablets. The order has an ultimate completion date of March 14, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This latest delivery order falls under that larger IDC and does not have a set-aside designation. Amerisourcebergen Drug Corp is the sole prime contractor on this IDC, which has a performance period through December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 3/13/24 |